Currently held
- Agent 4 — Dip Buyer (Frozen)long5 sh @ $205.26 · stop $188.84+$77.20 unrealized
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
‘Whoever Wins, AI Wins’: Trump Brushes Aside Slowdown Calls as Ex-Senator Demands an AI IPO Freeze
Trump told CNBC that slowing AI down is off the table, but a former senator wants an executive order freezing AI company IPOs before another chip gets trained. The calls to pump the brakes and the pressure to floor it landed on the same Monday morning.
WRB's Solid Growth Comes With a Premium Valuation - Hold or Buy?
W. R. Berkley's underwriting discipline, record investment income and AI gains support earnings, while global risks and competition remain headwinds.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
WRB's Solid Growth Comes With a Premium Valuation - Hold or Buy?
W. R. Berkley's underwriting discipline, record investment income and AI gains support earnings, while global risks and competition remain headwinds.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
‘Whoever Wins, AI Wins’: Trump Brushes Aside Slowdown Calls as Ex-Senator Demands an AI IPO Freeze
Trump told CNBC that slowing AI down is off the table, but a former senator wants an executive order freezing AI company IPOs before another chip gets trained. The calls to pump the brakes and the pressure to floor it landed on the same Monday morning.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Graham Value All-Stars (GVAS) Emit 10 Brilliant September Buys
The September GVAS portfolio highlights 10 ideal, fair-priced large-cap value stocks with strong dividend yields and positive free cash flow margins.
Can MCY Sustain Policy Growth Amid Rising Auto Competition?
Mercury General's rising policy base and premium growth position it to gain personal auto customers as competition intensifies and pricing moderates.
Can PGR's Telematics Edge Strengthen Its Underwriting Advantage?
Progressive's telematics and driving data support risk selection and claims efficiency, while stronger competition raises the need for underwriting discipline.
ROOT's Partnership Strategy Push Could Unlock Profitable Growth
Root's expanding partnerships diversify distribution and support underwriting gains, but higher acquisition costs could test profitability.
3 Big Reasons to Love Progressive (PGR)
Progressive has been treading water for the past six months, recording a small return of 4.4% while holding steady at $215.87. The stock also fell short of the S&P 500’s 13.6% gain during that period.
3 Insurers to Watch as Competition in Personal Auto Intensifies
Personal auto is shifting from rate-driven growth to competition-driven growth, favoring insurers like TRV, ALL and PGR with stronger underwriting.
SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For September 2026
4-Factor Dividend Growth Strategy targets high-quality, growth-oriented dividend stocks using a rules-based, four-metric screen. Learn more about the strategy here.
Progressive (PGR) Outperforms Broader Market: What You Need to Know
In the closing of the recent trading day, Progressive (PGR) stood at $223.91, denoting a +1.14% move from the preceding trading day.
The "Untouchable" List: Stocks That Short Sellers Won't Dare Bet Against
Why Short Sellers Are Running Scared from These Stocks
CB Stock Trades at 1.62x Book Value: Is the Valuation Worth It?
Chubb's strong underwriting, commercial growth and investment income support earnings, while catastrophe losses and softer pricing pose risks.
Insurers Are Buying Back More Stock as Pricing Softens
Stock buybacks among P&C insurers could be coming just in time to help support earnings.
First American's Housing Business Faces High Mortgage-Rate Pressure
FAF faces residential pressure from high mortgage rates, but strong commercial title activity and investment income offer support.
Why Is CNA Financial (CNA) Down 8.1% Since Last Earnings Report?
CNA Financial (CNA) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
How Berkshire’s New CEO Plans to Protect Iowa Power Costs From Hyperscaler Data Center Expansion
Berkshire Hathaway CEO Greg Abel said the company will only provide power for new data centers if other utility customers benefit. In a wide-ranging interview Wednesday morning with CNBC from Tokyo—where Abel is visiting with several large Japanese trading companies in which Berkshire has investments—the CEO discussed how Berkshire’s big utility, Berkshire Hathaway Energy, approaches data centers.
The Cincinnati Insurance Company Chief Claims Officer Announces Retirement
Cincinnati Financial Corporation (Nasdaq: CINF) announced that Marc J. Schambow, CPCU, AIM, ASLI, chief claims officer for its property casualty subsidiaries, led by The Cincinnati Insurance Company, will retire in January 2027.
Travelers Institute Announces Fall 2026 Wednesdays with Woodward® Webinar Schedule
HARTFORD, Conn., September 02, 2026--The Travelers Institute, the public policy division of The Travelers Companies, Inc. (NYSE: TRV), today announced its Wednesdays with Woodward fall 2026 webinar schedule. The virtual series – hosted by Joan Woodward, President of the Travelers Institute and Executive Vice President of Public Policy at Travelers – convenes economists, former government officials, corporate executives and policy experts to examine pressing issues at the intersection of insuranc
Stewart Expands Commercial Energy & Infrastructure Capabilities with Acquisition of Tower Title
HOUSTON, September 02, 2026--Stewart Information Services Corporation (NYSE:STC) today announced the acquisition of Tower Title, a leading national provider of telecommunications-focused title services. The acquisition strengthens Stewart’s National Commercial Services (NCS), specifically the company’s Energy & Infrastructure group, by adding a highly complementary infrastructure business that expands service capabilities, increases transaction volume and further diversifies the company's commer
Is Progressive Stock Underperforming the S&P 500?
Progressive has lagged the broader S&P 500 over the past year, although Wall Street analysts remain moderately bullish on the stock’s outlook.
Best Income Stocks to Buy for September 2nd
CURI, HMN and LCUT made it to the Zacks Rank #1 (Strong Buy) income stocks list on September 2, 2026.
Best Value Stocks to Buy for September 2nd
LCUT, SLDE and HMN made it to the Zacks Rank #1 (Strong Buy) value stocks list on September 2, 2026.
Aon's $17 Billion USI Deal: A Costly Bet on Middle-Market Growth
Aon's $17B USI acquisition expands its middle-market reach and specialty capabilities, but adds debt and puts execution under pressure.
Wall Street Analysts See a 25.18% Upside in HCI Group (HCI): Can the Stock Really Move This High?
The average of price targets set by Wall Street analysts indicates a potential upside of 25.2% in HCI Group (HCI). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.
Stewart Strengthens Title Capabilities Through Acquisition of ProTitleUSA and DocSolutionUSA
HOUSTON, September 01, 2026--Stewart Information Services Corporation (NYSE: STC) today announced it has acquired ProTitleUSA (ProTitle) and DocSolutionUSA (DocSolution), two companies that together provide a comprehensive suite of title, mortgage related documents and due diligence services that support servicers, investors and capital markets clients throughout the real estate and mortgage lifecycle.
AIMIA PROVIDES UPDATE ON ITS SHARE BUYBACKS FOR AUGUST
Aimia Inc. (TSX: AIM) (JSE: AII) announced today that it repurchased and settled for cancellation a total of 97,150 of its common shares in the month of August 2026 under the Company's normal course issuer bid program ("NCIB"). The total represents 0.1% of Aimia's 88,128,585 common shares outstanding as at August 31, 2026.
US Debt is Nearing $40.1 Trillion: Top Three Stock Sectors Set to Benefit
The US debt is now nearing the important milestone of $40.1 trillion a few days after it crossed the $40T milestone. Top stock sectors set to benefit
Agent 7 — Day Trader — decide: skip
PGR is down 2.35% intraday with no attributable headline, suggesting broad selling pressure or sector rotation rather than a news-driven spike that might quickly reverse. With 260 minutes remaining there is ample time for continuation into the close. The macro context shows 5Y5Y forward inflation (T5YIFR) running 1.6σ above its 24-month trend, which is modestly negative for rate-sensitive names like PGR (an insurer whose float income and reserve discounting are sensitive to rate expectations). Elevated inflation expectations can compress P/E multiples for financials and increase loss-cost concerns for property/casualty insurers. No news catalyst is present to drive a reversal, and the absence of headline risk cuts both ways — no snap-back catalyst either. The move is meaningful at 2.35% but not extreme enough to signal exhaustion or a climactic flush. Thin evidence for a reversal push; lean modestly toward continuation down, though conviction is limited given the lack of a specific catalyst and the need to watch for any midday stabilization. Probability set at 0.52 — marginal continuation bias, consistent with taking a small short position within the system's bounded risk framework.
Agent 7 — Day Trader — day_trade_skipped
PGR is down 2.35% intraday with no attributable headline, suggesting broad selling pressure or sector rotation rather than a news-driven spike that might quickly reverse. With 260 minutes remaining there is ample time for continuation into the close. The macro context shows 5Y5Y forward inflation (T5YIFR) running 1.6σ above its 24-month trend, which is modestly negative for rate-sensitive names like PGR (an insurer whose float income and reserve discounting are sensitive to rate expectations). Elevated inflation expectations can compress P/E multiples for financials and increase loss-cost concerns for property/casualty insurers. No news catalyst is present to drive a reversal, and the absence of headline risk cuts both ways — no snap-back catalyst either. The move is meaningful at 2.35% but not extreme enough to signal exhaustion or a climactic flush. Thin evidence for a reversal push; lean modestly toward continuation down, though conviction is limited given the lack of a specific catalyst and the need to watch for any midday stabilization. Probability set at 0.52 — marginal continuation bias, consistent with taking a small short position within the system's bounded risk framework.
Progressive: Strong Underwriting, But Limited Margin Of Safety
Progressive Corporation demonstrates robust risk management and client growth, maintaining high profitability. Read more on PGR stock here.
UBS Maintains Neutral on Progressive, Raises Price Target to $234
UBS analyst Brian Meredith maintains Progressive (NYSE:PGR) with a Neutral and raises the price target from $225 to $234.
Progressive: July Results Show The Growth Mix Is Changing
Agent 7 — Day Trader — decide: skip
PGR is up 1.62% today, a moderate but meaningful move suggesting real institutional flow. No news headlines are present, which is neutral — absence of catalyst doesn't negate price action. The macro context shows 5-year forward inflation expectations (T5YIFR) elevated at 1.8σ above trend, which creates a modestly unfavorable backdrop for rate-sensitive sectors broadly. PGR as an insurer is somewhat rate-sensitive (investment income, reserve discounting), but is less directly pressured than banks or utilities — partial headwind at most. With 100 minutes remaining, there is ample time for continuation into the close. The move magnitude (1.62%) is below the threshold of high-conviction momentum (2-5%), suggesting this is a solid but not explosive trend day. No reversal signals are visible from the data provided. On balance, lean slight continuation: the move has real price discovery, time is sufficient, and no compelling reason to fade exists. Probability set modestly above 0.5 reflecting ordinary momentum without strong amplifying or reversing factors.
Agent 7 — Day Trader — day_trade_skipped
PGR is up 1.62% today, a moderate but meaningful move suggesting real institutional flow. No news headlines are present, which is neutral — absence of catalyst doesn't negate price action. The macro context shows 5-year forward inflation expectations (T5YIFR) elevated at 1.8σ above trend, which creates a modestly unfavorable backdrop for rate-sensitive sectors broadly. PGR as an insurer is somewhat rate-sensitive (investment income, reserve discounting), but is less directly pressured than banks or utilities — partial headwind at most. With 100 minutes remaining, there is ample time for continuation into the close. The move magnitude (1.62%) is below the threshold of high-conviction momentum (2-5%), suggesting this is a solid but not explosive trend day. No reversal signals are visible from the data provided. On balance, lean slight continuation: the move has real price discovery, time is sufficient, and no compelling reason to fade exists. Probability set modestly above 0.5 reflecting ordinary momentum without strong amplifying or reversing factors.
Agent 7 — Day Trader — decide: skip
PGR is up 1.86% intraday — a meaningful move representing real institutional flow. No headline catalyst is identifiable, but absence of news doesn't negate momentum; this appears to be technical or sector-driven buying. The macro context shows the 5Y5Y forward inflation rate running 1.8σ above trend, which is modestly headwind for rate-sensitive names, though PGR as a P&C insurer is less directly rate-sensitive than banks or REITs — its earnings power is more tied to underwriting and loss ratios than duration. With 215 minutes remaining (roughly 3.5 hours), there is ample time for continuation. The move is below the 2% threshold where mean-reversion risk accelerates, keeping the momentum thesis intact. No reversal signals or fade pattern is evident from the data provided. Balancing the supportive time window and real buying conviction against the mild macro headwind from elevated inflation expectations, this is an ordinary momentum setup with no strong reason to expect fade — probability sits modestly above the 0.5 threshold.
Agent 7 — Day Trader — day_trade_skipped
PGR is up 1.86% intraday — a meaningful move representing real institutional flow. No headline catalyst is identifiable, but absence of news doesn't negate momentum; this appears to be technical or sector-driven buying. The macro context shows the 5Y5Y forward inflation rate running 1.8σ above trend, which is modestly headwind for rate-sensitive names, though PGR as a P&C insurer is less directly rate-sensitive than banks or REITs — its earnings power is more tied to underwriting and loss ratios than duration. With 215 minutes remaining (roughly 3.5 hours), there is ample time for continuation. The move is below the 2% threshold where mean-reversion risk accelerates, keeping the momentum thesis intact. No reversal signals or fade pattern is evident from the data provided. Balancing the supportive time window and real buying conviction against the mild macro headwind from elevated inflation expectations, this is an ordinary momentum setup with no strong reason to expect fade — probability sits modestly above the 0.5 threshold.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $12.27 cash available; close=$213.95.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $1.68 cash available; close=$213.95.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Is Brown Advisory’s Bet on Progressive’s Data Edge Reframing the PGR Investment Narrative?
In June, Brown Advisory disclosed that it had initiated a position in The Progressive Corporation (NYSE:PGR), citing the insurer’s leading role in the U.S. personal insurance market, low-cost products, and data-driven customer segmentation. This institutional vote of confidence underscores how Progressive’s scale and analytics-focused model are being viewed as key advantages in a soft insurance market with non-deferrable demand. Now we’ll examine how Brown Advisory’s focus on Progressive’s...
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $1.68 cash available; close=$213.95.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $8.25 cash available; close=$215.33.
Is Progressive (PGR) Undervalued After Brown Advisory Took A Position?
Progressive (PGR) is back in focus after Brown Advisory initiated a position in June, citing the insurer's role in the U.S. personal insurance market and its data driven approach to customer segmentation. See our latest analysis for Progressive. Over the past year Progressive has seen its share price move in fits and starts, with an 8.52% 90 day share price return contrasting with a 6.35% decline in 1 year total shareholder return. This points to improving near term momentum after a softer...
Progressive (PGR) Is Winning Market Share. Can It Keep Growing?
Brown Advisory, an investment management company, released its “Brown Advisory Global Leaders Strategy” for the second quarter of 2026 investor letter. A copy of the letter can be downloaded here. Brown Advisory’s Global Leaders Strategy delivered a net return of 4.6% in the second quarter of 2026, underperforming its benchmark, the MSCI ACWI Net Index, […]
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $8.25 cash available; close=$215.33.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $13.54 cash available; close=$215.37.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Progressive's Combined Ratio Widened to 87.1 Last Quarter. What That Says About the Growth Machine.
Progressive has had a good run, but further growth appears to require some trade-offs.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $13.54 cash available; close=$215.37.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $3.31 cash available; close=$215.34.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.31 cash available; close=$215.34.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $1.39 cash available; close=$215.35.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $1.39 cash available; close=$215.35.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $15.74 cash available; close=$212.76.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $15.74 cash available; close=$212.76.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $15.74 cash available; close=$212.76.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $15.74 cash available; close=$212.76.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $12.52 cash available; close=$212.73.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $12.52 cash available; close=$212.73.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $58.44 cash available; close=$210.75.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Progressive Q2 Earnings Call Highlights
Progressive (NYSE:PGR) used its second-quarter investor event to outline its strategy for expanding in bundled auto and home insurance, emphasizing improvements in its property business and the growth potential among “Robinsons,” its term for consistently insured households that bundle auto and home
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $58.44 cash available; close=$210.75.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $42.43 cash available; close=$210.69.
The Progressive Corporation 2026 Q2 - Results - Earnings Call Presentation
2026-08-05. The following slide deck was published by The Progressive Corporation in conjunction with their 2026 Q2 earnings call.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $42.43 cash available; close=$210.69.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $11.23 cash available; close=$210.46.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Progressive (PGR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Progressive (PGR) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
The Progressive Corporation (PGR) Q2 2026 Earnings Call Transcript
The Progressive Corporation (PGR) Q2 2026 Earnings Call August 4, 2026 9:30 AM EDTCompany ParticipantsJulianna PaterraSusan Griffith - President, CEO &...
The Progressive Corporation Q2 2026 Earnings Call Summary
Moby summary of The Progressive Corporation's Q2 2026 earnings call
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 8 — Dip Buyer (Peer-Aware) — dip_skipped
Progressive is a fundamentally strong insurer with consistent underwriting discipline and growth, and a 12.1% drop from its 30-day high is notable but not catastrophic. However, the drop lacks a clearly identifiable overreaction catalyst — there are no insider cluster buys (only sales), no unusual call flow, and no SEC filings confirming a specific temporary impairment. The lone mildly positive news headline is generic, and the Financials sector has underperformed SPY over 5 days (-1.63pts), suggesting some macro/sector drag rather than a pure idiosyncratic overreaction. The 10Y yield at 4.75% is a structural headwind for insurance valuations, and insider sales (even if 10b5-1 routine) are a mild negative signal on a dip. Earnings are 90 days away, so no imminent binary risk.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $11.23 cash available; close=$210.46.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $10.15 cash available; close=$210.38.
SCHD-Inspired 4-Factor Dividend Growth Strategy Selections For August 2026
The 4-Factor Dividend Growth Strategy, inspired by SCHD, targets high-quality, growth-oriented dividend stocks using four key metrics for selection.
Why Progressive (PGR) Could Be One of the Best Insurance Stocks to Own
Ariel Investments, an investment management company, released its “Appreciation Fund” Q2 2026 investor letter. A copy of the letter can be downloaded here. The fund gained 13.71% in the second quarter of 2026, slightly outperforming the Russell Midcap Value Index’s 13.40% return but trailing the Russell Midcap Index’s 13.83% gain. Strong contributions from several holdings, […]
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $5.13 cash available; close=$210.38.
Agent 8 — Dip Buyer (Peer-Aware) — insufficient_capital
Wanted to buy but only $2.80 cash available; close=$211.42.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $10.15 cash available; close=$210.38.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $3.83 cash available; close=$211.42.
Chubb's Solid Growth Comes With a Premium Valuation - Hold or Buy?
Chubb's disciplined underwriting, broad-based premium growth and rising investment income continue to support earnings and long-term growth.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $3.83 cash available; close=$211.42.
Agent 5 — Dip Buyer (Evolving) — insufficient_capital
Wanted to buy but only $2.50 cash available; close=$213.28.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $2.80 cash available; close=$211.42.
Agent 8 — Dip Buyer (Peer-Aware) — insufficient_capital
Wanted to buy but only $12.52 cash available; close=$213.28.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.50 cash available; close=$213.28.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $12.52 cash available; close=$213.28.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $7.23 cash available; close=$213.38.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $10.42 cash available; close=$213.38.
BRK.B Lags Industry in a Year: Is the Stock Still a Buy?
Berkshire Hathaway's insurance float, $370B-plus liquidity and diversified businesses reinforce its long-term earnings and investment capacity.
THG Q2 Earnings Beat on Personal Lines Gains, Revenues Miss
THG's Q2 earnings rise 22.1% and beat estimates as Personal Lines gains, lower catastrophe losses and investment income offset a revenue miss.
Should BRK.B Stock Be in Your Portfolio Ahead of Q2 Earnings?
Berkshire Hathaway is set to report Q2 earnings. Revenues are expected to grow with insurance strength, investment income and buybacks likely to support results.
Why Insurance Stocks Can Be Some of the Market's Best Long-Term Compounders
Insurance companies are among the largest institutional investors, thanks to this unique feature of their business.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $2.05 cash available; close=$213.83.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $14.99 cash available; close=$213.83.
The Zacks Analyst Blog Highlights INTC, DELL and PGR
Intel, Dell and Progressive headline new Zacks research, with AI-driven growth opportunities, demand trends and competitive pressures shaping their outlooks.
The GoodHaven Fund 2026 Semi-Annual Contributors And Detractors
The GoodHaven Fund's top three detractors, all long-term winners, accounted for approximately 400 basis points of negative performance in the period. Read more here.
Earn 10-15% Potential Income: Monthly Options Series (Aug. 2026)
The series targets generating 12â15% annualized income through disciplined selling of PUT and BUY-WRITE CALL options on large-cap stocks. Check out the strategy here.
Progressive (PGR) Could Be 7% Undervalued After Half Year 2026 Results
Progressive (PGR) is back in focus after reporting half year 2026 results, with revenue of US$45,797 million and net income of US$6,129 million compared with the prior year period. See our latest analysis for Progressive. Progressive’s recent half year result and upcoming investor event are playing out against a share price of US$213.83, with a 1 day share price return of 3.26% and a 90 day share price return of 6.44%, while the 1 year total shareholder return declined 8.95% but the 5 year...
Agent 7 — Day Trader — decide: buy
PGR is up 2.33% on a Morgan Stanley upgrade — a named, credible catalyst that signals institutional conviction and is likely to drive follow-on buying from funds that were underweight or seeking confirmation. Upgrades from major banks often see sustained buying through the session as portfolio managers act on the revised rating. With 355 minutes remaining (essentially the full remainder of the trading day), there is ample time for the move to extend toward the +3% target. The macro context (T10Y2Y at 2σ below trend, mild curve flattening) is slightly supportive of defensives and insurance names like PGR, which are less rate-sensitive than banks in a flattening regime — no meaningful headwind here. No reversal signals or fade patterns are noted; the move appears directional rather than a gap-and-stall. Probability set at 0.65 reflecting clear catalyst + time remaining + supportive macro, without reaching 0.70+ absent confirmation of volume or sector-wide tailwind.
Agent 7 — Day Trader opened long 13 @ $211.89
Agent 7 — Day Trader closed long 13 @ $213.24 (+$17.55)
EOD forced close — day trader never carries overnight
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $22.47 cash available; close=$207.08.
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $51.28 cash available; close=$212.23.
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $51.28 cash available; close=$212.23.
Agent 5 — Dip Buyer (Evolving) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $22.68 cash available; close=$205.90.
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $51.28 cash available; close=$212.23.
Agent 5 — Dip Buyer (Evolving) — decide: buy
[not executed — reserve_floor_or_cash] Wanted to buy but only $22.68 cash available; close=$205.90.
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] [not executed — reserve_floor_or_cash] Wanted to buy but only $51.28 cash available; close=$212.23.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $22.68 cash available; close=$205.90.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $22.68 cash available; close=$205.90.
Agent 8 — Dip Buyer (Peer-Aware) — decide: buy
[not executed — reserve_floor_or_cash] Wanted to buy but only $51.28 cash available; close=$212.23.
Agent 7 — Day Trader — decide: skip
PGR is down 1.83% intraday with no attributable headline catalyst. The move is meaningful but below the 2-5% threshold that would signal strong conviction flow. With 330 minutes remaining (essentially a full trading day remaining until the 3:45 ET cutoff), there is ample time for the move to continue or reverse. The macro context shows T10Y2Y at 1.5σ below its 24-month trend, which favors defensives in a bear-flattening environment — PGR as an insurance name carries some defensive characteristics, which could provide a mild headwind to further downside. However, the absence of a reversal catalyst and the real price flow already established gives a slight edge to continuation. No news means no obvious reason to fade. Probability is marginally above 0.5: momentum bias with no strong continuation pressure identified.
Agent 8 — Dip Buyer (Peer-Aware) — decide: skip_no_cash
Wanted to buy but only $51.28 cash available; close=$212.23.
Agent 5 — Dip Buyer (Evolving) — decide: skip_no_cash
Wanted to buy but only $10.58 cash available; close=$212.23.